| Date Filed | Type | Description |
| 08/14/2023 |
SC 13G
| LYTTON LAURENCE W reports a 5.7% stake in Alimera Sciences, Inc. |
| 07/20/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 05/11/2023 |
SC 13G
| LYTTON LAURENCE W reports a 5.1% stake in Miromatrix Medical Inc. |
| 03/07/2023 |
SC 13G/A
| LYTTON LAURENCE W reports a 5.5% stake in Scientific Industries, Inc. |
| 02/22/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/13/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 11/23/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 11/23/2022 |
SC 13G
| LYTTON LAURENCE W reports a 8.8% stake in TFF Pharmaceuticals, Inc. |
| 05/20/2022 |
SC 13G
| LYTTON LAURENCE W reports a 5.4% stake in EMCORE Corporation |
| 05/18/2022 |
SC 13G
| LYTTON LAURENCE W reports a 5.9% stake in Paratek Pharmaceuticals, Inc. |
| 05/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/30/2022 |
SC 13G
| LYTTON LAURENCE W reports a 5.7% stake in Scientific Industries, Inc. |
| 03/04/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/15/2022 |
SC 13G/A
| LYTTON LAURENCE W reports a 9.3% stake in Apollo Endosurgery, Inc. |
| 02/15/2022 |
SC 13G/A
| LYTTON LAURENCE W reports a 4.1% stake in Diamedica Therapeutics, Inc. |
| 02/15/2022 |
SC 13G/A
| LYTTON LAURENCE W reports a 5.7% stake in Vertex Energy, Inc. |
| 02/15/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/15/2022 |
SC 13G/A
| LYTTON LAURENCE W reports a 0.8% stake in Ra Medical Systems, Inc. |
| 02/15/2022 |
SC 13G/A
| LYTTON LAURENCE W reports a 1.8% stake in Emcore Corporation |
| 02/15/2022 |
SC 13G/A
| LYTTON LAURENCE W reports a 0.7% stake in Viracta Therapeutics, Inc. |
| 02/15/2022 |
SC 13G/A
| LYTTON LAURENCE W reports a 2.5% stake in Cidara Therapeutics, Inc. |
| 02/14/2022 |
SC 13G/A
| LYTTON LAURENCE W reports a 5.9% stake in Duos Technologies Group, Inc. |
| 02/14/2022 |
SC 13G/A
| LYTTON LAURENCE W reports a 10% stake in Giga-tronics Incorporated |
|